Literature DB >> 957598

[A contribution to the pseudo-LE-syndrome. Investigations of the cardiovascular system, abdominal organs, lymphatic system and drug histories (author's transl)].

J Senekamp, E Genth, I Flenker, H Hermanutz, J Wagner, L Beltz, H G Rohner.   

Abstract

13 of 30 patients suffering from pseudo-LE-syndrome showed a usually reversible enlargement of the heart during the acute stage of the disease. In two patients carditis occurring in pseudo-LE-syndrome lead to congestive heart failure and an additional patient died in the acute stage of carditis. As opposed to Systemic Lupus Erythematosus hypertension did not occur in a higher frequency than normal. In five cases cardiac catheter examinations showed slight elevation of the end-diastolic pressure in the right ventricle, in two cases an abnormal high mean pressure in the right atrium and a systolic gradient at the pulmonic valve was found. -Scintigrams showed definite enlargement of the spleen and to a lesser degree enlargement of the liver was seen. Laparascopy showed multiple concretions after peritonitis. Lymphographic changes in the retroperitoneal lymph nodes and lymphatic ducts were not observed in contrast to rheumatic diseases. Drug histories in most cases discovered intake of Venopyronum dragees prior to onset of the disease. But recurrent attacks of the disease also occurred without further intake of the drug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 957598     DOI: 10.1007/BF01614292

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  [Pseudo-LE syndrome after treatment with Venopyronum dragees] (author's transl)

Authors:  J A Schwarz; H Jost
Journal:  Dtsch Med Wochenschr       Date:  1975-08-01       Impact factor: 0.628

2.  Antinative DNA antibodies as a reaction to pyrazole drugs.

Authors:  M F Grayson; V M Martin; R L Markham
Journal:  Ann Rheum Dis       Date:  1975-08       Impact factor: 19.103

3.  [On the question of drug-induced pseudo-LE syndrome: preliminary results in 58 cases (author's transl)].

Authors:  D Maas; H Schubothe; J Sennekamp; E Genth; G Maerker-Alzer; M Droese; P W Hartl; K Schumacher
Journal:  Dtsch Med Wochenschr       Date:  1975-07-25       Impact factor: 0.628

4.  [Simultaneous demonstration of nuclear and mitochondrial antibodies by immunofluorescence].

Authors:  J Sennekamp; G Brunner; I Stroehmann
Journal:  Dtsch Med Wochenschr       Date:  1973-06-15       Impact factor: 0.628

5.  [Mitochondrial antibodies in nonhepatic diseases. Occurrence, significance and differential diagnosis].

Authors:  P A Berg; U Traunecker; A Märker
Journal:  Dtsch Med Wochenschr       Date:  1973-06-08       Impact factor: 0.628

6.  [Lupus erythematosus-like syndrome with antimitochondrial antibodies. Report on 21 cases].

Authors:  D Maas; K P Merz; J Hahn; H Schubothe
Journal:  Verh Dtsch Ges Inn Med       Date:  1972

7.  [Involvement of lymph nodes in disseminated lupus erythematosus].

Authors:  D Ricken; L Beltz; H J Marsteller; J Sennekamp
Journal:  Verh Dtsch Ges Inn Med       Date:  1971

8.  [The BBC study. Applied epidemiology of ischemic heart diseases].

Authors:  S Heyden
Journal:  Arch Kreislaufforsch       Date:  1967-06

9.  Lymphographic findings in granulomatous inflammations and connective tissue diseases. Differential diagnosis between these diseases and lymphomas.

Authors:  J Rauste
Journal:  Acta Radiol Suppl       Date:  1972

10.  [Have people with varicose veins venous disease? Examinations of 3641 men and 781 women of the Basel study. II].

Authors:  M Schneider; L Glaus; L K Widmer; H J Leu
Journal:  Dtsch Med Wochenschr       Date:  1973-02-23       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.